This week in medical devices, medtechinsider considers the case of Capella, an Irish medical device company, which, like many companies, is postponing doing business in the United States because of what it perceives as the difficulty of finding regulatory approval; on Orthotec, Thomas Blair describes the saga of DePuy’s recalled hip implants; and Massdevice exlpains how FDA has approved the first umbilical cord blood product.

• RFID Tags Can Save Paper and Lives (medtechinsider)
• ASR Implants Still Making Headlines in Australia (Orthotec)
• An Inexpensive Microscopy and Spectroscopy Hack for the iPhone (Medical Electronics Design)
• Stryker plans to lay off 5% of its workforce ahead of the med-tech tax (Massdevice)
• FDA Issues Two Draft Guidances on Medical Device Development, Studies (ASC Review)

— Brian Buntz